vs

Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $32.2M, roughly 1.6× OptimizeRx Corp). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs 15.6%, a 404.7% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs -0.2%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 28.0%).

Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

ARR vs OPRX — Head-to-Head

Bigger by revenue
ARR
ARR
1.6× larger
ARR
$50.4M
$32.2M
OPRX
Growing faster (revenue YoY)
ARR
ARR
+298.1% gap
ARR
297.9%
-0.2%
OPRX
Higher net margin
ARR
ARR
404.7% more per $
ARR
420.2%
15.6%
OPRX
Faster 2-yr revenue CAGR
ARR
ARR
Annualised
ARR
108.0%
28.0%
OPRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARR
ARR
OPRX
OPRX
Revenue
$50.4M
$32.2M
Net Profit
$211.7M
$5.0M
Gross Margin
74.8%
Operating Margin
26.6%
Net Margin
420.2%
15.6%
Revenue YoY
297.9%
-0.2%
Net Profit YoY
555.9%
6535.9%
EPS (diluted)
$2.43
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARR
ARR
OPRX
OPRX
Q4 25
$50.4M
$32.2M
Q3 25
$38.5M
$26.1M
Q2 25
$33.1M
$29.2M
Q1 25
$36.3M
$21.9M
Q4 24
$12.7M
$32.3M
Q3 24
$21.3M
Q2 24
$7.0M
$18.8M
Q1 24
$19.7M
Net Profit
ARR
ARR
OPRX
OPRX
Q4 25
$211.7M
$5.0M
Q3 25
$159.3M
$779.0K
Q2 25
$-75.6M
$1.5M
Q1 25
$27.3M
$-2.2M
Q4 24
$-46.4M
$-78.0K
Q3 24
$-9.1M
Q2 24
$-48.4M
$-4.0M
Q1 24
$-6.9M
Gross Margin
ARR
ARR
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
ARR
ARR
OPRX
OPRX
Q4 25
26.6%
Q3 25
7.9%
Q2 25
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
-40.2%
Q2 24
-19.9%
Q1 24
-25.5%
Net Margin
ARR
ARR
OPRX
OPRX
Q4 25
420.2%
15.6%
Q3 25
413.5%
3.0%
Q2 25
-228.4%
5.2%
Q1 25
75.2%
-10.0%
Q4 24
-366.8%
-0.2%
Q3 24
-42.8%
Q2 24
-693.8%
-21.3%
Q1 24
-35.0%
EPS (diluted)
ARR
ARR
OPRX
OPRX
Q4 25
$2.43
$0.27
Q3 25
$1.49
$0.04
Q2 25
$-0.94
$0.08
Q1 25
$0.32
$-0.12
Q4 24
$-0.91
$0.00
Q3 24
$-0.50
Q2 24
$-1.05
$-0.22
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARR
ARR
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$63.3M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$2.3B
$128.3M
Total Assets
$21.0B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARR
ARR
OPRX
OPRX
Q4 25
$63.3M
$23.4M
Q3 25
$44.2M
$19.5M
Q2 25
$141.2M
$16.6M
Q1 25
$49.1M
$16.6M
Q4 24
$68.0M
$13.4M
Q3 24
$16.1M
Q2 24
$126.6M
Q1 24
Total Debt
ARR
ARR
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
ARR
ARR
OPRX
OPRX
Q4 25
$2.3B
$128.3M
Q3 25
$2.1B
$122.3M
Q2 25
$1.7B
$119.3M
Q1 25
$1.7B
$116.3M
Q4 24
$1.4B
$117.0M
Q3 24
$114.5M
Q2 24
$1.2B
$121.0M
Q1 24
$122.5M
Total Assets
ARR
ARR
OPRX
OPRX
Q4 25
$21.0B
$176.9M
Q3 25
$19.4B
$170.3M
Q2 25
$16.2B
$169.3M
Q1 25
$15.5B
$167.8M
Q4 24
$13.5B
$171.2M
Q3 24
$165.2M
Q2 24
$10.1B
$172.9M
Q1 24
$176.4M
Debt / Equity
ARR
ARR
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARR
ARR
OPRX
OPRX
Operating Cash FlowLast quarter
$124.2M
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.59×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARR
ARR
OPRX
OPRX
Q4 25
$124.2M
$7.1M
Q3 25
$-37.8M
$3.2M
Q2 25
$25.0M
$4.6M
Q1 25
$101.5M
$3.9M
Q4 24
$261.5M
$198.0K
Q3 24
$1.8M
Q2 24
$27.1M
$782.0K
Q1 24
$2.1M
Free Cash Flow
ARR
ARR
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
ARR
ARR
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
ARR
ARR
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
ARR
ARR
OPRX
OPRX
Q4 25
0.59×
1.41×
Q3 25
-0.24×
4.11×
Q2 25
2.98×
Q1 25
3.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons